Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals.

Mellors J. et al, (2025), Nat Commun, 16

Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies.

Gunst JD. et al, (2025), Nat Commun, 16

MHC-related protein 1-restricted recognition of cancer via a semi-invariant TCR-α chain.

Dolton G. et al, (2025), J Clin Invest, 135

Learning patterns of HIV-1 resistance to broadly neutralizing antibodies with reduced subtype bias using multi-task learning.

Igiraneza AB. et al, (2024), PLoS Comput Biol, 20

Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infection.

Sun W. et al, (2024), J Exp Med, 221

Impact of antiretroviral therapy during primary HIV infection on T-cell immunity after treatment interruption.

Tipoe T. et al, (2024), Eur J Immunol

Obesity Differs from Diabetes Mellitus in Antibody and T Cell Responses Post COVID-19 Recovery.

Ali M. et al, (2024), Clin Exp Immunol

Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recovery.

Thornhill JP. et al, (2024), AIDS, 38, 679 - 688

Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination.

Nel C. and Frater J., (2024), Front Immunol, 15

Gonadal androgens are associated with decreased type I interferon production by plasmacytoid dendritic cells and increased IgG titres to BNT162b2 following co-vaccination with live attenuated influenza vaccine in adolescents.

Sampson OL. et al, (2024), Front Immunol, 15

Prevalence of resistance-associated viral variants to the HIV-specific broadly neutralising antibody 10-1074 in a UK bNAb-naïve population.

Zacharopoulou P. et al, (2024), Front Immunol, 15

Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions.

Kopycinski J. et al, (2023), Sci Rep, 13

SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.

Barnes E. et al, (2023), Nat Med, 29, 1760 - 1774

Obesity Differs from Diabetes Mellitus in Antibody and T Cell Responses Post COVID-19 Recovery

Ali M. et al, (2023)

Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses.

Dijokaite-Guraliuc A. et al, (2023), Cell Rep, 42

Paediatric HIV slow-progression is associated with early CD8+ T-cell PD-1 expression and a stem-like phenotype.

Adriano Vieira V. et al, (2023), JCI Insight

Analysis of broadly neutralising antibody resistance in adolescents and young people living with HIV

Zacharopoulou P. et al, (2023), HIV MEDICINE, 24, 35 - 35

Gonadal androgens are associated with decreased type I interferon production by pDCs and increased IgG titres to BNT162b2 following co-vaccination with live attenuated influenza vaccine in adolescents

Sampson O. et al, (2023)

Learning patterns of HIV-1 co-resistance to broadly neutralizing antibodies with reduced subtype bias using multi-task learning

Igiraneza AB. et al, (2023)

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses.

Murray SM. et al, (2022), Nat Rev Immunol, 1 - 13

Load More

Include forthcoming?